Promising Pharmaceutical Stocks To Research - March 19th

Key Points

• Eli Lilly (LLY), Novo Nordisk (NVO), and Pfizer (PFE) were flagged by MarketBeat's screener as the top pharmaceutical stocks to watch after posting the highest dollar trading volume among pharma names in recent days.
• Eli Lilly and Novo Nordisk are front-runners in diabetes and obesity treatments—Lilly markets drugs such as Mounjaro, Trulicity and Zepbound, while Novo Nordisk focuses on diabetes/obesity care and rare-disease therapies.
• Pfizer remains a diversified biopharma with major vaccine and infectious-disease franchises (including Comirnaty and Paxlovid), though all three names carry typical sector risks from clinical results, regulatory actions, patents and pricing.

Eli Lilly and Company, Novo Nordisk A/S, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is researching, developing, manufacturing, and marketing prescription drugs and therapies. For investors, these stocks are driven by factors like clinical trial results, regulatory approvals, patent protection and pricing, and can offer substantial growth potential but also heightened volatility and regulatory risk. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Read Our Latest Research Report on NVO

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Read Our Latest Research Report on PFE

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.